Home
>
National Drug Code (NDC)
>
Budeprion
Budeprion - 0093-5350-56 - (Bupropion Hydrochloride)
Drug Information of Budeprion
| Product NDC: | 0093-5350 |
| Proprietary Name: | Budeprion |
| Non Proprietary Name: | Bupropion Hydrochloride |
| Active Ingredient(s): | 150 mg/1 & nbsp; Bupropion Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Budeprion
| Product NDC: | 0093-5350 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077284 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080530 |
Package Information of Budeprion
| Package NDC: | 0093-5350-56 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5350-56) |
NDC Information of Budeprion
| NDC Code | 0093-5350-56 |
| Proprietary Name | Budeprion |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5350-56) |
| Product NDC | 0093-5350 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bupropion Hydrochloride |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080530 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
